Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy

International Journal of Cardiology

Volumn 86, Issue 2-3, 2002, Pages 281-287

  Burger, Andrew J ^a   D’Elia, John A ^b   Weinrauch, Larry A ^c   Lerman, Israel ^d   Gaur, Abhishek ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Autonomic neuropathy; Diabetes mellitus; Heart rate variability; Nephropathy

Indexed keywords

CHOLESTEROL; CREATININE;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEINURIA;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036888350     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00346-7     Document Type: Article

References (33)

1. Gerritsen J., Dekker J.M., TenVoorde B.J., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension or a history of cardiovascular disease. Diabetes Care. 24:2001;1793-1798.
2. Dekker J.M., Schuten E.G., Klootwijk P., Pool J., Swwenne C.A., Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle aged and elderly men: the Zurphen Study. Am J Epidemiol. 145:1997;899-908.
3. Ewing D.J., Campbell I.W., Clarke B.F. The natural history of diabetic autonomic neuropathy. Q J Med. 49:1980;95-108.
4. Ewing D.J., Boland O., Neilson J.M., Cho C.G., Clarke B.F. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 34:1991;182-185.
5. Ziegler D., Dannehl K., Spuler M., Gries F.A. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabetes Med. 9:1992;806-814.
6. Toyry J.P., Niskanen L.K., Mantysaari M.J., Lansimies E.A., Uusitupa M.I. Occurrence, predictors and clinical significance of autonomic neuropathy in NIDDM. Ten years follow-up from the diagnosis. Diabetes. 45:1996;308-315.
7. Zola B., Kahn J.K., Juni J.E., Vinic A.I. Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischaemic heart disease. J Clin Endocrinol Metab. 63:1986;208-214.
8. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 93:1996;1043-1065.
9. Masaoka S., Lev-Ran A., Hill L.R., Vakil G., Hon E.H. Heart rate variability in diabetes; relationship to age and duration of the disease. Diabetes Care. 8:1985;64-68.
10. Piha S.J., Halonen J.P. Effect of disease duration on cardiac autonomic reflexes in young patients with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 18:1985;61-67.
11. Bergstrom B., Lilja B., Osterlin S., Sundkvist G. Autonomic neuropathy in type 1 diabetes: influence of duration and other diabetic complications. Acta Med Scand. 222:1987;147-154.
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 122:1995;561-568.
13. Burger A.J., Weinrauch L.A., D'Elia J.A., Aronson D. Effect of glycemic control on heart rate variability in the type 1 diabetic patients with cardiac autonomic neuropathy. Am J Cardiol. 84:1999;687-691.
14. Malpas S.C., Maling T.J. Heart-rate variability and cardiac autonomic function in diabetes. Diabetes. 39:1990;1177-1181.
15. Meinhold J.A., et al. Low prevalence of cardiac autonomic neuropathy in type 1 diabetic patients without nephropathy. Diabetes Med. 18:2001;607-613.
16. Bellavere F., Balzani I., De Masi G., Carraro P., Cobelli C., Thomaseth K. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes. 41:1992;633-640.
17. Molgaard H., Christensen P.O., Sorensen K.S., Christensen C.K., Mogensen C.S. Association of 24 h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes. 41:1992;312-317.
18. Burger A.J., Charlamb M., Weinrauch L.A., D'Elia J.A. Short- and long-term reproducibility of heart rate variability in patients with long-standing type 1 diabetes. Am J Cardiol. 80:1997;1198-1202.
19. Zander E., Schultz B., Henke P., Grimmberger E., Zander G., Detlet G.H. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care. 12:1989;259-264.
20. Weinrauch L., Kennedy F.P., Gleason R.E., Keough J., Delia J. Relationship between autonomic function and progression of renal disease in diabetic proteinuria. Am J Hypertens. 11:1998;302-308.
21. Spallone V., Gambardella S., Maiello M.R., Barini A., Frontoni S., Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care. 17:1994;578-584.
22. Lafferty A.R., Werther G.A., Clarke C.F. Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care. 23:2000;533-538.
23. Bell D.S., Ketchum C.H., Robinson C.A., Wagenknecht L.E., Williams B.T. Microalbuminuria associated with diabetic neuropathy. Diabetes Care. 15:1992;528-531.
24. Savage S., Estacio R.O., Jeffers B., Schrier R.W. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 19:1996;1243-1248.
25. Stella P., Ellis D., Maser R.E., Orchard T.J. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications. 14:2000;1-627.
26. Steinberg A.A., Mars R.L., Goldman D.S., Percy R.F. Effect of end-stage renal disease on decreased heart rate variability. Am J Cardiol. 82:1998;1156-1158.
27. Caramori M.L., Gross J.L., Pecis M., de Azevedo M.J. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care. 22:1999;1512-1516.
28. Pecis M., Azevedo M.J., Moraes R.S., Ferlin E.L., Gross J.L. Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients. Diabetes Care. 23:2000;989-993.
29. Guzzetti S., Dassi S., Pecis M., et al. Altered pattern of circadian neural control of heart period in mild hypertension. J Hypertens. 9:1991;831-838. erratum appears in J Hypertens 1991;9(10):following H48.
30. Langewitz W., Ruddel H., Schachinger H. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am Heart J. 127:1994;122-128.
31. Kontopoulos A.G., Athyros V.G., Didangelos T.P., et al. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care. 20:1997;355-361.
32. Weston P.J., Gill G.V. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus. The dead in bed syndrome revisited. Diabetes Med. 16:1999;626-631.
33. Sawicki P.T., Dahne R., Bender R., Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia. 39:1986;77-81.